Shiv Rajan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shiv Rajan has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Vijay Kumar
Department of Surgical Oncology, King’s George Medical University, Lucknow, India
18 shared publications - Naseem Akhtar
Department of Surgical Oncology King George's Medical University Lucknow India
16 shared publications - Deep Chakrabarti
Genitourinary Oncology, The Royal Marsden NHS Foundation Trust, London, United Kingdom
11 shared publications Arun Chaturvedi
Surgical Oncology, King George’s Medical University, Uttar Pradesh, Lucknow, India
10 shared publications- Sameer Gupta
Department of Surgical Oncology, King George’s Medical University, Lucknow, India
8 shared publications Naseem Akhtar
Department of Surgical Oncology, King George’s Medical University, Lucknow, India
7 shared publications
Latest Publications
- 29 January 2026
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 78 (3) , 1659-1667
Factors Predicting Contralateral Neck Recurrence in Purely Lateralized Oral Cancer: An Observational Study
- 29 January 2026
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 78 (3) , 1659-1667
Factors Predicting Contralateral Neck Recurrence in Purely Lateralized Oral Cancer: An Observational Study
- 17 September 2025
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 17 (6) , 1-7
Awake Nebulized Indocyanine Green (ICG) for Tracheobronchial Fluorescence: A Safety and Feasibility Study in Minimally Invasive Esophagectomy
Indocyanine green (ICG) imaging has shown potential in improving minimally invasive esophagectomy (MIE) safety in many ways. However, the risk of tracheobronchial tree injury remains a major concern. Real-time ICG-guided tracheobronchial fluorescence (TBF) is an innovative application of this technology for preventing such injuries. This study aimed to evaluate the feasibility and safety of nebulized ICG administered using an affordable nebulizer during the awake position to achieve TBF during the single-lung ventilation phase of MIE. An observational study was conducted on 30 consecutive patients undergoing McKeown’s MIE. A compressor-type nebulizer was used to administer 5 ml (2.5 mg/ml) of aerosolized ICG before anesthesia induction. The real-time TBF was assessed with a near-infrared imaging system during the thoracic phase. All 30 patients had locally advanced squamous cell carcinoma and received neoadjuvant therapy. Of these, 21 (70%) had tumors in the middle third. Median time for nebulization was 9 min (8–11), and the time interval between this and the first TBF visualization was 90 min (80–150). TBF visualization was achieved in 30/30 (100%) and persisted throughout the thoracic phase in all (100%). No intraoperative tracheobronchial injury or ICG allergy was observed. Grade 3 or 4 pulmonary complications occurred in 13.3% of cases. Administering nebulized ICG while awake results in effective real-time TBF during MIE, improving surgical precision and safety. This simple, affordable, and reliable method shows promise for decreasing airway-related complications and improving outcomes in esophageal cancer surgery.
- 17 September 2025
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 17 (6) , 1-7
Awake Nebulized Indocyanine Green (ICG) for Tracheobronchial Fluorescence: A Safety and Feasibility Study in Minimally Invasive Esophagectomy
Indocyanine green (ICG) imaging has shown potential in improving minimally invasive esophagectomy (MIE) safety in many ways. However, the risk of tracheobronchial tree injury remains a major concern. Real-time ICG-guided tracheobronchial fluorescence (TBF) is an innovative application of this technology for preventing such injuries. This study aimed to evaluate the feasibility and safety of nebulized ICG administered using an affordable nebulizer during the awake position to achieve TBF during the single-lung ventilation phase of MIE. An observational study was conducted on 30 consecutive patients undergoing McKeown’s MIE. A compressor-type nebulizer was used to administer 5 ml (2.5 mg/ml) of aerosolized ICG before anesthesia induction. The real-time TBF was assessed with a near-infrared imaging system during the thoracic phase. All 30 patients had locally advanced squamous cell carcinoma and received neoadjuvant therapy. Of these, 21 (70%) had tumors in the middle third. Median time for nebulization was 9 min (8–11), and the time interval between this and the first TBF visualization was 90 min (80–150). TBF visualization was achieved in 30/30 (100%) and persisted throughout the thoracic phase in all (100%). No intraoperative tracheobronchial injury or ICG allergy was observed. Grade 3 or 4 pulmonary complications occurred in 13.3% of cases. Administering nebulized ICG while awake results in effective real-time TBF during MIE, improving surgical precision and safety. This simple, affordable, and reliable method shows promise for decreasing airway-related complications and improving outcomes in esophageal cancer surgery.
- 28 October 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (3) , 367-370
Solitary fibrous tumor of the chest wall
Solitary fibrous tumors (SFTs) are uncommon mesenchymal tumors that primarily develop in the visceral pleura. The chest wall is an extremely rare site for the origin of these tumors and therefore presents unique challenges for diagnosis and management. We present a rare case of solitary fibrous tumors of the chest wall (SFTCW), necessitating extensive resection and complex reconstruction.
- 28 October 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (3) , 367-370
Solitary fibrous tumor of the chest wall
Solitary fibrous tumors (SFTs) are uncommon mesenchymal tumors that primarily develop in the visceral pleura. The chest wall is an extremely rare site for the origin of these tumors and therefore presents unique challenges for diagnosis and management. We present a rare case of solitary fibrous tumors of the chest wall (SFTCW), necessitating extensive resection and complex reconstruction.
- 19 June 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 15 (4) , 762-767
Skin Flap Necrosis in Inguinal Lymph Node Dissection
Inguinal skin flap necrosis (SFN) is a significant clinical problem associated with inguinal lymph node dissection (ILND). The aetiology of SFN is multifactorial, and its manifestations vary widely. Thermal damage caused by electrocautery during the elevation of the skin flap may contribute to this problem, which has not been studied previously. This prospective, observational study included patients undergoing ILND from January 2020 to July 2022. Based on the technique of raising the inguinal skin flaps, the patients were divided into two groups (cold knife or electrocautery). The remaining part of the procedure was the same. The inguinal wound was examined and photographed to assess the SFN. A total of 42 patients were included (21 in each group). Age, gender, body mass index (BMI), alcohol or tobacco consumption, immune compromised status, and serum albumin were comparable (p > 0.05). The average time required to elevate flaps was 13.14 vs. 11.47 min (p = 0.0231), and gauze soakage was 2.05 vs. 1.52 (p < 0.0001) with a cold knife compared to electrocautery. The incidence of SFN and surgical site infection (SSI) was significantly lower with the use of a cold knife [4.8% vs. 33.3% (p = 0.045) and 0% vs. 19% (p = 0.0378)]. Grade 3 necrosis was observed only with electrocautery use. Compared to conventional electrocautery, the cold knife technique lowers the incidence of SFN and SSI. Further research with a larger sample size and a standardized definition is needed to validate these results.
- 19 June 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 15 (4) , 762-767
Skin Flap Necrosis in Inguinal Lymph Node Dissection
Inguinal skin flap necrosis (SFN) is a significant clinical problem associated with inguinal lymph node dissection (ILND). The aetiology of SFN is multifactorial, and its manifestations vary widely. Thermal damage caused by electrocautery during the elevation of the skin flap may contribute to this problem, which has not been studied previously. This prospective, observational study included patients undergoing ILND from January 2020 to July 2022. Based on the technique of raising the inguinal skin flaps, the patients were divided into two groups (cold knife or electrocautery). The remaining part of the procedure was the same. The inguinal wound was examined and photographed to assess the SFN. A total of 42 patients were included (21 in each group). Age, gender, body mass index (BMI), alcohol or tobacco consumption, immune compromised status, and serum albumin were comparable (p > 0.05). The average time required to elevate flaps was 13.14 vs. 11.47 min (p = 0.0231), and gauze soakage was 2.05 vs. 1.52 (p < 0.0001) with a cold knife compared to electrocautery. The incidence of SFN and surgical site infection (SSI) was significantly lower with the use of a cold knife [4.8% vs. 33.3% (p = 0.045) and 0% vs. 19% (p = 0.0378)]. Grade 3 necrosis was observed only with electrocautery use. Compared to conventional electrocautery, the cold knife technique lowers the incidence of SFN and SSI. Further research with a larger sample size and a standardized definition is needed to validate these results.
- 25 February 2024
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 20 (3) , 407-415
Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing chemoradiotherapy
Background: Cancer stem cell biomarkers SRY (sex‐determining region Y)‐box 2 (SOX2) and octamer‐binding transcription factor 4 (Oct4) account for radioresistance in cervical squamous cell cancers (CSCCs). Their clinical implications are limited and contradictory.Methods: In this prospective cohort study, we recruited patients with FIGO IB2‐IVA CSCC treated with primary chemoradiotherapy on regular follow‐up. Tissue biopsy specimens were evaluated for SOX2 and Oct4 expression by immunohistochemistry, quantified by a product of proportion and intensity scores.Results: A total of 59 patients were included. Most had a moderately differentiated (81%), keratinizing (59%) CSCC, and ≥FIGO stage IIB disease (95%). SOX2 expression (high:low 21:38 patients) and Oct4 expression (high:low 4:55 patients) had a significant interrelation (p = 0.005, odds ratio (95% CI) − 1.23 (1.004–1.520)). At a median follow‐up of 36 months, the 3‐year overall survival (OS) was 60% and 53% for low and high SOX2 expression (p = 0.856), and 54% and 100% for low and high Oct4 expression (p = 0.114). The 3‐year disease‐frese survival (DFS) was 65% and 50% in the low and high SOX2 expression (p = 0.259), and 59% and 75% for low and high Oct4 expression (p = 0.598). SOX2 expression was the only variable significantly associated with a lower OS and DFS on regression analysis.Conclusion: Our study demonstrated a trend toward improved OS and DFS with low SOX2 and high Oct4 expression in CSCC patients undergoing chemoradiotherapy.
- 25 February 2024
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 20 (3) , 407-415
Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing chemoradiotherapy
Background: Cancer stem cell biomarkers SRY (sex‐determining region Y)‐box 2 (SOX2) and octamer‐binding transcription factor 4 (Oct4) account for radioresistance in cervical squamous cell cancers (CSCCs). Their clinical implications are limited and contradictory.Methods: In this prospective cohort study, we recruited patients with FIGO IB2‐IVA CSCC treated with primary chemoradiotherapy on regular follow‐up. Tissue biopsy specimens were evaluated for SOX2 and Oct4 expression by immunohistochemistry, quantified by a product of proportion and intensity scores.Results: A total of 59 patients were included. Most had a moderately differentiated (81%), keratinizing (59%) CSCC, and ≥FIGO stage IIB disease (95%). SOX2 expression (high:low 21:38 patients) and Oct4 expression (high:low 4:55 patients) had a significant interrelation (p = 0.005, odds ratio (95% CI) − 1.23 (1.004–1.520)). At a median follow‐up of 36 months, the 3‐year overall survival (OS) was 60% and 53% for low and high SOX2 expression (p = 0.856), and 54% and 100% for low and high Oct4 expression (p = 0.114). The 3‐year disease‐frese survival (DFS) was 65% and 50% in the low and high SOX2 expression (p = 0.259), and 59% and 75% for low and high Oct4 expression (p = 0.598). SOX2 expression was the only variable significantly associated with a lower OS and DFS on regression analysis.Conclusion: Our study demonstrated a trend toward improved OS and DFS with low SOX2 and high Oct4 expression in CSCC patients undergoing chemoradiotherapy.
- Open Access
- 10 May 2023
- Published by Medknow in Journal of Minimal Access Surgery
- Vol. 19 (3) , 450-452
Uniportal video-assisted thoracoscopic Ivor Lewis oesophagectomy
Standard minimally invasive Ivor Lewis oesophagectomy is performed through a multiport technique using carbon dioxide. However, access to video-assisted thoracoscopic surgery (VATS) is increasingly shifting to a single-port approach due to its proven safety and efficacy in lung surgeries. Therefore, the preamble of this submission is to describe, ‘How I do differently’ uniportal VATS MIO in three major steps: (a) VATS dissection through a single 4-cm incision in a semi-prone position without artificial capnothorax; (b) fluorescence dye to check conduit perfusion and (c) intrathoracic overlay anastomosis with a linear stapler.
- 10 May 2023
- Published by Medknow in Journal of Minimal Access Surgery
- Vol. 19 (3) , 450-452
Open AccessUniportal video-assisted thoracoscopic Ivor Lewis oesophagectomy
Standard minimally invasive Ivor Lewis oesophagectomy is performed through a multiport technique using carbon dioxide. However, access to video-assisted thoracoscopic surgery (VATS) is increasingly shifting to a single-port approach due to its proven safety and efficacy in lung surgeries. Therefore, the preamble of this submission is to describe, ‘How I do differently’ uniportal VATS MIO in three major steps: (a) VATS dissection through a single 4-cm incision in a semi-prone position without artificial capnothorax; (b) fluorescence dye to check conduit perfusion and (c) intrathoracic overlay anastomosis with a linear stapler.
- 11 December 2021
- Published by Wiley in Journal of Surgical Oncology
- Vol. 125 (4) , 631-641
Radical surgery for de novo gallbladder carcinoma—Single‐center analysis of prognostic factors and survival outcomes from an endemic region
Background and Objective: Gallbladder cancer (GBC) is an aggressive malignancy where curative resection is possible in few and survival is poor. There are limited data on outcomes in patients with de novo GBC from endemic regions undergoing surgery for curative intent. We report survival outcomes in this group of patients from a region with high incidence of disease.Methods: We reviewed the records of all GBC patients (2014–2018) and included those who underwent radical cholecystectomy (RC) for de novo GBC. Univariable and multivariable analyses were performed to identify factors influencing recurrence and survival.Results: A total of 649 patients with GBC were evaluated for surgery and curative intent surgery was attempted in 246 (38%) patients. Of these 246 patients, RC was performed in 115 patients, with histologically confirmed de novo GBC. Locally advanced disease (≥stage IIIB) was present in 52 (45.2%) patients. Median time to recurrence and overall survival (OS) were 31 and 36 months, respectively. Lymph node positivity (p = 0.005) and grade significantly influenced OS on multivariable analysis.Conclusion: Satisfactory survival outcomes are possible after RC for de novo GBC. Extended resections performed in high volume centers combined with appropriate adjuvant treatment can offer significant survival benefits, with acceptable morbidity and mortality rates.
- 11 December 2021
- Published by Wiley in Journal of Surgical Oncology
- Vol. 125 (4) , 631-641
Radical surgery for de novo gallbladder carcinoma—Single‐center analysis of prognostic factors and survival outcomes from an endemic region
Background and Objective: Gallbladder cancer (GBC) is an aggressive malignancy where curative resection is possible in few and survival is poor. There are limited data on outcomes in patients with de novo GBC from endemic regions undergoing surgery for curative intent. We report survival outcomes in this group of patients from a region with high incidence of disease.Methods: We reviewed the records of all GBC patients (2014–2018) and included those who underwent radical cholecystectomy (RC) for de novo GBC. Univariable and multivariable analyses were performed to identify factors influencing recurrence and survival.Results: A total of 649 patients with GBC were evaluated for surgery and curative intent surgery was attempted in 246 (38%) patients. Of these 246 patients, RC was performed in 115 patients, with histologically confirmed de novo GBC. Locally advanced disease (≥stage IIIB) was present in 52 (45.2%) patients. Median time to recurrence and overall survival (OS) were 31 and 36 months, respectively. Lymph node positivity (p = 0.005) and grade significantly influenced OS on multivariable analysis.Conclusion: Satisfactory survival outcomes are possible after RC for de novo GBC. Extended resections performed in high volume centers combined with appropriate adjuvant treatment can offer significant survival benefits, with acceptable morbidity and mortality rates.
- 24 August 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (8) , e244218
Polymorphous adenocarcinoma of the submandibular gland
Polymorphous adenocarcinoma (PA) of the salivary glands is a rare malignancy that predominantly affects the minor salivary glands of the palate. Major salivary gland involvement is rare (<5%). The submandibular gland is a highly unusual location for this tumour. Recently, the WHO has updated the classification of salivary gland tumours in which the PA subtype has been modified. We report a very uncommon case of a classical variant of PA involving the submandibular gland in a 49-year-old woman managed at our institute and discuss the most recent pathological criteria for diagnosis, management strategy and prognosis of PA.
- 24 August 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (8) , e244218
Polymorphous adenocarcinoma of the submandibular gland
Polymorphous adenocarcinoma (PA) of the salivary glands is a rare malignancy that predominantly affects the minor salivary glands of the palate. Major salivary gland involvement is rare (<5%). The submandibular gland is a highly unusual location for this tumour. Recently, the WHO has updated the classification of salivary gland tumours in which the PA subtype has been modified. We report a very uncommon case of a classical variant of PA involving the submandibular gland in a 49-year-old woman managed at our institute and discuss the most recent pathological criteria for diagnosis, management strategy and prognosis of PA.
- 16 August 2021
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 19 (4) , 1-8
Predicting Complete Cytoreduction in Ovarian Cancer Patients by RECIST 1.1 Criteria Following Neoadjuvant Chemotherapy
- 16 August 2021
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 19 (4) , 1-8
Predicting Complete Cytoreduction in Ovarian Cancer Patients by RECIST 1.1 Criteria Following Neoadjuvant Chemotherapy